Revolutionary DNA test by BillionToOne could transform early cancer detection and prenatal screening in the US.
I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? — M.N. ANSWER: When screening patients for cancer, the ...
Detection Market · GlobeNewswire Inc. The cell-free tumor DNA detection market is set to experience significant growth, ...
MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...
We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting ...
Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.
Cell-free DNA (cfDNA) and matched tumor sample from patients with BTC were analyzed using targeted next-generation sequencing (NGS) assay and compared. We sought to define the molecular profile of ...
Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
When Erica Barnell was an MD/PhD student at Washington University in St. Louis, she met a woman who had stage four colorectal cancer (CRC). The woman was only 52 years old—more than a decade younger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results